To investigate the effect of tocilizumab on putative cancer stem cells in vivo, we performed immunofluorescence staining for ALDH1 and CD44 in mucoepidermoid carcinoma xenografts (Figure 6A). Here, ALDH1A1 is linked to mucoepidermoid carcinoma.